1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Raia Drogasil S.A.
  6. News
  7. Summary
    RADL3   BRRADLACNOR0

RAIA DROGASIL S.A.

(RADL3)
  Report
Delayed Quote. Delayed Bolsa de Valores de Sao Paulo - 05/24 04:07:34 pm
18.86 BRL   +1.02%
05/04TRANSCRIPT : Raia Drogasil S.A., Q1 2022 Earnings Call, May 04, 2022
CI
05/03Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03RAIA DROGASIL S.A. : 1st quarter results
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

RAIA DROGASIL S.A. : Ex-dividend day for interim dividend

12/09/2021 EDT

An interim dividend is removed today from Raia Drogasil S.A.'s share.



© Factset 2021
All news about RAIA DROGASIL S.A.
05/04TRANSCRIPT : Raia Drogasil S.A., Q1 2022 Earnings Call, May 04, 2022
CI
05/03Raia Drogasil S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/03RAIA DROGASIL S.A. : 1st quarter results
CO
05/03RAIA DROGASIL S.A. : 1st quarter report
CO
05/03RAIA DROGASIL S.A. : Press Release
CO
05/02RAIA DROGASIL S.A.(BOVESPA : RADL3) added to Brazil IBRX 50 Index
CI
04/05RAIA DROGASIL S.A. : Ex-dividend day for
FA
02/23TRANSCRIPT : Raia Drogasil S.A., Q4 2021 Earnings Call, Feb 23, 2022
CI
02/22Brazil's Raia Drogasil posts Q4 net profit of 187 mln reais
RE
02/22Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
More news
Financials
Sales 2022 28 787 M 5 941 M 5 941 M
Net income 2022 914 M 189 M 189 M
Net Debt 2022 1 142 M 236 M 236 M
P/E ratio 2022 34,3x
Yield 2022 1,02%
Capitalization 31 077 M 6 414 M 6 414 M
EV / Sales 2022 1,12x
EV / Sales 2023 0,97x
Nbr of Employees 50 141
Free-Float 66,8%
Chart RAIA DROGASIL S.A.
Duration : Period :
Raia Drogasil S.A. Technical Analysis Chart | RADL3 | BRRADLACNOR0 | MarketScreener
Technical analysis trends RAIA DROGASIL S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 18,86 BRL
Average target price 26,17 BRL
Spread / Average Target 38,8%
EPS Revisions
Managers and Directors
Marcílio D'Amico Pousada Chief Executive Officer
Antonio Carlos Coelho Vice President-Finance & Administration
Antonio Carlos Pipponzi Chairman
Marco Ambrogio Crespi Bonomi Independent Director
Sylvia de Souza Leão Wanderley Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RAIA DROGASIL S.A.-23.17%6 414
AIN HOLDINGS INC.-1.22%1 571
PETMED EXPRESS, INC.-17.78%420
QOL HOLDINGS CO., LTD.-13.50%353
HLS THERAPEUTICS INC.-10.13%340
NIHON CHOUZAI CO.,LTD.-14.33%279